Translate this page into:
Are genetic problems causes of autism in children? An etiological spectrum of secondary causes of autism spectrum disorder (ASD) – A retrospective study
*Corresponding author: Vykuntaraju K. Gowda, Department of Pediatric Neurology, Indira Gandhi Institute of Child Health, Bengaluru, Karnataka, India. drknvraju08@gmail.com
-
Received: ,
Accepted: ,
How to cite this article: Gowda VK, Rajesh RN, Srinivasan VM, Kinhal UV. Are genetic problems causes of autism in children? An etiological spectrum of secondary causes of autism spectrum disorder (ASD) – A retrospective study. Karnataka Paediatr J. 2025;40:254-5. doi: 10.25259/KPJ_35_2025
Dear Editor,
Autism spectrum disorder (ASD) is a neurodevelopmental disorder, with a prevalence estimated to be 0.0014 − 0.0012%.[1] Genetic testing has yielded a diagnostic yield of up to 30% with the use of exome or genome sequencing, making the latter the first tier of investigation in this group.[2] We aim to determine the aetiological spectrum of genetically proven causes using various molecular techniques, including chromosomal microarray, methylation studies, fragile X screening, and exome sequencing, as indicated clinically, among children with ASD. Included variants that were pathogenic/likely pathogenic only.
This is a retrospective chart review of all cases diagnosed as ASD (using the modified checklist for autism in toddlers, revised [MCHAT-R]) with positive genetic testing reports from the past 3 years at the paediatric neurology clinic. Out of 136 children, 79 were male (58%) with a mean age of 6 years (Standard deviation = 4.2). Monogenic disorders constituted 123 (90.5%): autosomal dominant disorders were most common - 58 (42.5%), followed by recessive disorders in 34 (25%) and X-linked inheritance in 31 (23%), chromosomal disorders - 10 (7.35%) and Fragile X syndrome constituted - 3 (2%) cases.
The common cause in females was Rett syndrome (37%), while it was non-syndromic monogenic in males (26%). Chromosomal defects included Angelman syndrome and Prader–Willi syndrome (10%). Monogenic syndromic causes include Mucopolysaccharidosis type 3 (11%), Coffin–Siris syndrome (10%), cerebral creatine deficiency (8%), neurofibromatosis 1 (5%), mucolipidosis (4%), tuberous sclerosis (4%), fragile X syndrome, and phenylketonuria (3%). Co-morbidities were global developmental delay (79%), seizures (45%), dysmorphism (44%), tone abnormalities 46% and microcephaly (32%).
Sheth et al. identified the aetiology in 30% of cases.[2] Sánchez Suárez et al. showed an overall diagnostic yield of 3.2% in autism and 12.7% in children with both autism and developmental delay.[3] Similar findings were noted in the current study. To conclude, exome sequencing is a helpful test that can detect most of the known aetiologies in children with autism.
Ethical approval:
Institutional Review Board has waived ethical approval for this study
Declaration of patient consent:
Patient’s consent not required as there are no patients in this study.
Conflicts of interest:
There are no conflicts of interest.
Use of artificial intelligence (AI)-assisted technology for manuscript preparation:
The authors confirm that there was no use of artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript and no images were manipulated using AI.
Financial support and sponsorship: Nil.
References
- Prevalence of autism spectrum disorder in Indian children: A systematic review and meta-analysis. Neurol India. 2019;67:100-4.
- [CrossRef] [PubMed] [Google Scholar]
- Comparative yield of molecular diagnostic algorithms for autism spectrum disorder diagnosis in India: Evidence supporting whole exome sequencing as first tier test. BMC Neurol. 2023;23:292.
- [CrossRef] [PubMed] [Google Scholar]
- Whole exome sequencing and panel-based analysis in 176 Spanish children with neurodevelopmental disorders: Focus on autism spectrum disorder and/or intellectual disability/global developmental delay. Genes (Basel). 2024;15:1310.
- [CrossRef] [PubMed] [Google Scholar]